Market Size of UAE Respiratory Devices Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 2.50 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
UAE Respiratory Devices Market Analysis
The United Arab Emirates (UAE) respiratory devices market is expected to register a CAGR of 2.5% during the forecast period.
Respiratory devices, such as ventilators, nebulizers, and other respiratory devices, had an immense need to manage COVID-19 patients. COVID-19 had worse outcomes for patients with respiratory diseases. For instance, according to the study published in PLOS ONE Journal in March 2021, patients from the UAE with prior comorbidities, including asthma, COPD, and chronic renal disease, had a higher mortality rate during hospitalization. Thus, the demand for respiratory devices increased during the pandemic in the UAE. However, post-pandemic, the market is expected to gain traction over the coming years because of declining COVID-19 cases and the resumption of hospital services.
The market is driven by factors such as the increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), tuberculosis (TB), asthma, sleep apnea, and technological advancements. For instance, according to the study published in the World Allergy Organization Journal in January 2022, the incidence of asthma in the United Arab Emirates was 13.5%. The increasing incidence of asthma in the United Arab Emirates is due to the presence of airborne pathologies due to changes in the weather conditions in the country. Hence, the demand for respiratory devices is expected to increase in the United Arab Emirates over the forecast period. Moreover, according to the study published in the World Allergy Organization Journal in October 2021, the prevalence of asthma, wheezing, and hay fever was higher in the 6- to 7-year-old group, while allergic rhinitis and atopic dermatitis were higher in the 13- to 14-year-old group in the UAE.
Furthermore, increasing R&D expenditure by innovators and generic players and technological advancements associated with respiratory devices are expected to fuel the UAE respiratory devices market. For instance, in January 2022, at Arab Health 2022, OES Medical debuted the ICU Ventilator. The Gemini-G100 is an electrically powered piston ICU ventilator with an integrated oxygen concentrator. The gadget was created for use in environments where a high-pressure oxygen supply is an issue.
Thus, all the aforementioned factors, such as the growing burden of chronic diseases and technological advancement, are expected to boost market growth over the forecast period. However, the high costs associated with the devices may hamper the market to a certain extent.
